INS and diabetes mellitus: Despite the above limitations, we suggest that even if there is no improvement in IR upon SVR, the improvement in the activity of β cells, evaluated here with the increase in HOMA-β and insulin in patients with obesity, prediabetes and diabetes, should be better studied.